Acumen Pharmaceuticals, Inc.
ABOS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001576885
No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Acumen Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 80 | 1 | 81 | +2 |
| Shares | 42.5M | 78.4K | 40.3M | −2.19M (−5.1%) |
| Value | $73.2M | $134.9K | $44.8M | −$28.2M (−38.6%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 78,446 | $86.3K | 0.00% |
| AQR Capital Management LLC | 41,735 | $45.9K | 0.00% |
| Thoroughbred Financial Services, LLC | 15,500 | $17.0K | 0.00% |
| Two Sigma Securities, LLC | 11,879 | $13.1K | 0.00% |
| The PNC Financial Services Group, Inc. | 4,446 | $4.89K | 0.00% |
| Meeder Asset Management Inc | 1,584 | $1.74K | 0.00% |
| N.E.W. Advisory Services LLC | 598 | $658 | 0.00% |
| EverSource Wealth Advisors, LLC | 486 | $535 | 0.00% |
| Rise Advisors, LLC | 373 | $410 | 0.00% |
| Coldstream Capital Management Inc | 311 | $343 | 0.00% |
| True Wealth Design, LLC | 29 | $32 | 0.00% |
Sold out (9)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Rock Springs Capital Management LP | 1,838,916 | $3.16M |
| American Century Companies Inc | 54,278 | $93.4K |
| Prelude Capital Management, LLC | 48,414 | $83.3K |
| Atom Investors LP | 33,678 | $57.9K |
| Verition Fund Management LLC | 19,445 | $33.4K |
| Susquehanna Fundamental Investments, LLC | 14,731 | $25.3K |
| ProShare Advisors LLC | 11,812 | $20.3K |
| Citadel Advisors LLC | 9,597 | $16.5K |
| Nisa Investment Advisors, LLC | 356 | $612 |
Not filed for Q1 2025 yet (1)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 78,446 | $134.9K |